AtriCure Reports Third Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to AtriCure Reports Third Quarter 2021 Financial Results

AtriCure Inc. (ATRC) PT Raised to $92 at Needham & Company

November 4, 2021 6:44 AM EDT

Needham & Company analyst Mike Matson raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $92.00 (from $90.00) while maintaining a Buy rating.

The analyst commented, "ATRC's 3Q21 revenue, EBITDA, and EPS all beat consensus. While it has only been 6 months since EPi-Sense's FDA... More

AtriCure (ATRC) Tops Q3 EPS by 10c

November 3, 2021 4:39 PM EDT

AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $70.5 million versus the consensus estimate of $68.68 million.


GUIDANCE:


AtriCure sees FY2021 EPS of ($1.20), versus the consensus of ($1.35). AtriCure... More